Articles published by Slingshot Biosciences

Slingshot Biosciences and Cellares Combine TruCytes™ Biomarker Controls with the Cell Q™ Platform to Enhance Quality and Automation in Cell Therapy Manufacturing

October 28, 2025

From Slingshot Biosciences

Via Business Wire

Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost

October 02, 2025

From Slingshot Biosciences

Via Business Wire

Slingshot Biosciences Appoints Glenn Bilawsky as CEO to Lead Strategic Expansion across Clinical Trial and Diagnostic Markets

May 28, 2025

From Slingshot Biosciences

Via Business Wire

Slingshot Biosciences Debuts TruCytes™ Potency—Cell Mimics for Scalable, Reproducible CAR-T Potency Assays

May 06, 2025

From Slingshot Biosciences

Via Business Wire

Slingshot Biosciences Welcomes Visionary Leader and Industry Expert Dr. Nimisha Srivastava as New Chief Operations Officer

December 04, 2024

From Slingshot Biosciences

Via Business Wire

Slingshot Unveils a Novel Cell Therapy-Focused Portfolio to Streamline Development while Improving Manufacturing and Clinical Trial Capabilities

March 26, 2024

From Slingshot Biosciences

Via Business Wire

Slingshot Biosciences Announces $11 Million in Series A3 Financing

February 06, 2023

From Slingshot Biosciences

Via Business Wire

Slingshot Biosciences Announces $23 Million in Series A Financing

July 22, 2021

From Slingshot Biosciences

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.